Stock listing

Oramed Pharmaceuticals Inc.

Selected listing: A1CTNU · LS · EUR · DE

Oramed Pharmaceuticals Inc. (Lang & Schwarz: A1CTNU), Health Technology. Latest release Jun 25, 2026: Oramed Releases Letter to Shareholders, Highlighting…

A1CTNU:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A1CTNU
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Oramed Pharmaceuticals Inc.

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

June 25, 2026

Lifeward Successfully Closes on Strategic Partnership with Oramed

March 24, 2026

Oramed and Lifeward Announce Strategic Transaction

January 12, 2026

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

January 12, 2026

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

January 7, 2026

All Oramed Pharmaceuticals Inc. news →

Research Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. company profile

View the public company page for Oramed Pharmaceuticals Inc. on 6ix.

Oramed Pharmaceuticals Inc. news

Read company news and market updates connected to Oramed Pharmaceuticals Inc..

Oramed Pharmaceuticals Inc. investor events

Find investor webinars, events, and replay context for Oramed Pharmaceuticals Inc..